Rethinking Clozapine Monitoring: 22 Years of Data
Psychopharmacology and Psychiatry Updates
00:00
Intro
This chapter explores a comprehensive study on the long-term risks of clozapine, particularly agranulocytosis, based on data from over 62,000 patients in Finland. It discusses the historical hesitance in prescribing this effective treatment for resistant schizophrenia and the implications of recent FDA panel decisions on monitoring practices.
Transcript
Play full episode
